Research map: The TAF3/SREBP2/cholesterol axis drives tumor progression in hepatocellular carcinoma

Back to the article

Papers in this map

  1. Hallmarks of Cancer: The Next Generation · Douglas Hanahan · 2011 · 67934 citations · Cited by this paper
  2. LRP8 drives cervical cancer lymph node metastasis by promoting epithelial-mesenchymal transition and VEGF-C secretion · 2026 · Related
  3. Hepatocellular carcinoma · Alejandro Forner · 2018 · 5718 citations · Cited by this paper
  4. Global trends in the burden of inflammatory bowel disease from 1990 to 2021: socioeconomic and sex-specific disparities with exploratory mendelian randomization analyses · 2026 · Related
  5. A global view of hepatocellular carcinoma: trends, risk, prevention and management · Ju Dong Yang · 2019 · 4457 citations · Cited by this paper
  6. Extranodal involvement defines distinct immune-molecular phenotypes and clinical outcomes in diffuse large b-cell lymphoma · 2026 · Related
  7. Causes and consequences of replication stress · Michelle K. Zeman · 2013 · 2177 citations · Cited by this paper
  8. Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma · 2026 · Related
  9. SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology · Hitoshi Shimano · 2017 · 1214 citations · Cited by this paper
  10. Serum TIMP-1 shows a potential association with metastatic disease in patients with pancreatic cancer: a pilot analysis without a healthy control cohort · 2026 · Related
  11. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities · Binlu Huang · 2020 · 968 citations · Cited by this paper
  12. Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma · 2026 · Related
  13. Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness · Shuhua Yue · 2014 · 964 citations · Cited by this paper
  14. Population-specific association and risk discrimination utility of the cardiometabolic index for prevalent hypertension–diabetes comorbidity: insights from CHARLS and NHANES · 2026 · Related
  15. The General Transcription Machinery and General Cofactors · Mary C. Thomas · 2006 · 949 citations · Cited by this paper
  16. Beyond polarization: a receptor-centered framework for macrophage function and therapy in skin diseases · 2026 · Related
  17. BIOCHEMISTRY AND STRUCTURAL BIOLOGY OF TRANSCRIPTION FACTOR IID (TFIID) · Stephen Kevin Burley · 1996 · 738 citations · Cited by this paper
  18. Dissecting PCD-driven molecular landscapes in AML: a multi-omic framework for prognostication and therapeutic targeting · 2026 · Related
  19. Identification and Distinct Regulation of Yeast TATA Box-Containing Genes · Andrew D Basehoar · 2004 · 719 citations · Cited by this paper
  20. Thromboembolic risk in subcutaneous versus intravenous immunoglobulin therapy: a systematic review and narrative meta-synthesis · 2026 · Related
  21. Molecular and histological correlations in liver cancer · Julien Caldéraro · 2019 · 615 citations · Cited by this paper
  22. H3K4me3 Interactions with TAF3 Regulate Preinitiation Complex Assembly and Selective Gene Activation · Shannon M. Lauberth · 2013 · 499 citations · Cited by this paper
  23. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression · Sung‐Hwan Moon · 2018 · 466 citations · Cited by this paper
  24. Statins: a repurposed drug to fight cancer · Wen Jiang · 2021 · 429 citations · Cited by this paper
  25. Advances in targeting ‘undruggable’ transcription factors with small molecules · Matthew J. Henley · 2021 · 415 citations · Cited by this paper
  26. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target · Dabin Liu · 2018 · 291 citations · Cited by this paper
  27. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma · Qian Song · 2023 · 290 citations · Cited by this paper
  28. Metabolic reprogramming in the tumor microenvironment of liver cancer · Jian Lin · 2024 · 245 citations · Cited by this paper
  29. Conversion therapy and maintenance therapy for primary hepatocellular carcinoma · Hongyuan Zhou · 2021 · 190 citations · Cited by this paper
  30. Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment · Adele Chimento · 2019 · 186 citations · Cited by this paper
  31. Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6 · Rongya Tao · 2013 · 180 citations · Cited by this paper
  32. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma · Zhikui Liu · 2018 · 176 citations · Cited by this paper
  33. Control of Embryonic Stem Cell Lineage Commitment by Core Promoter Factor, TAF3 · Zhe J. Liu · 2011 · 175 citations · Cited by this paper
  34. Rafting Down the Metastatic Cascade: The Role of Lipid Rafts in Cancer Metastasis, Cell Death, and Clinical Outcomes · Joshua D. Greenlee · 2020 · 151 citations · Cited by this paper
  35. The current evidence on statin use and prostate cancer prevention: are we there yet? · Mahmoud A. Alfaqih · 2016 · 141 citations · Cited by this paper
  36. Obesity, Cholesterol Metabolism, and Breast Cancer Pathogenesis · Donald Patrick McDonnell · 2014 · 119 citations · Cited by this paper
  37. FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells · Jia Z. Shen · 2020 · 116 citations · Cited by this paper
  38. Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma · Etienne Ho Kit Mok · 2022 · 112 citations · Cited by this paper
  39. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer · Shanshan Gao · 2021 · 101 citations · Cited by this paper

Source: OpenAlex (CC0)